merged_eu-covid-vaccines.txt
<question_number>1</question_number>
<answer>The ruling gives new momentum to critics of Ursula von der Leyen, potentially complicating her chances of securing a second term, especially given the tight vote expected.</answer>
<question_number>2</question_number>
<answer>The article implies that concerns about the lack of transparency on the vaccine contracts have contributed to a sense of distrust among European voters, which has coincided with a surge in far-right politicians gaining seats in the European Parliament.</answer>
<question_number>3</question_number>
<answer>The article suggests that von der Leyen's handling of the vaccine contracts has strained her political alliances, particularly with center-left lawmakers including the Greens, who are incensed by her management of the coronavirus crisis.</answer>
<question_number>4</question_number>
<answer>The article implies that the European Commission's vaccine procurement strategy, marked by a lack of transparency, has contributed to a sense of distrust among European voters, which has coincided with the rise of far-right politicians in the European Parliament.</answer>
<question_number>5</question_number>
<answer>The court's ruling, which criticizes the European Commission's lack of transparency, may reinforce public distrust and contribute to the political environment that has seen a rise in far-right politicians in the European Parliament.</answer>
<question_number>6</question_number>
<answer>The timing of the court's ruling, just ahead of the vote, may influence the decision of undecided or critical lawmakers, potentially affecting the outcome of the vote on von der Leyen's future.</answer>
<question_number>7</question_number>
<answer>The EU's vaccine procurement strategy initially started slowly and conservatively but later caught up and surpassed other major countries after von der Leyen secured a contract with Pfizer-BioNTech.</answer>
<question_number>8</question_number>
<answer>The European Commission's statement that it needed to strike a balance between transparency and protecting business interests contradicts its past actions, as the court found that the commission did not demonstrate that wider access to the vaccine contract details would undermine commercial interests.</answer>
<question_number>9</question_number>
<answer>The court's ruling supports the importance of freedom of information, which is also a key issue in The New York Times' pending legal case against the European Commission for access to text messages between von der Leyen and the CEO of Pfizer.</answer>
<question_number>10</question_number>
<answer>The court's ruling may further erode public trust in the EU's pandemic response, especially in light of recent political shifts and the rise of far-right politicians who have capitalized on dissatisfaction with EU policies.</answer>